Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2581974 | Chemico-Biological Interactions | 2008 | 8 Pages |
Abstract
We propose that the strategy of PSA-based early phase II clinical trials accompanied by experimental human xenograft studies, to assess the reliability of PSA response to reflect tumor response, allows for a concise, relatively fast test system that is able to screen the various treatment options for chemoprevention in a relatively short period of time.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Wytske M. van Weerden, Fritz H. Schröder,